Analysts’ Weekly Ratings Changes for Nutex Health (NUTX)

Several analysts have recently updated their ratings and price targets for Nutex Health (NASDAQ: NUTX):

• 7/28/2026 – Nutex Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 7/20/2026 – Nutex Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 7/12/2026 – Nutex Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 7/10/2026 – Nutex Health was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
• 6/29/2026 – Nutex Health was upgraded by Zacks Research to “hold”.
• 6/26/2026 – Nutex Health is now covered by B. Riley Financial, Inc.. They set a “buy” rating and a $290.00 price target on the stock.
• 6/2/2026 – Nutex Health is now covered by Lake Street Capital. They set a “buy” rating and a $235.00 price target on the stock.

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.